Gene therapy has recently reached the front line in the treatments of different diseases. Although graphene oxide has been widely used as a gene vector, its clinical application is limited by its scarce inhomogeneity due to the different synthetic methods adopted for its synthesis. Recently, we have developed the preparation of a new classof graphene oxide, named oxo -G,obtained by a rigorous synthetic method with controlled size and surface chemistry. oxo-G has been successfully applied for the production of reduced graphene oxide with remarkable conductivity. Here, we applied oxo-G to gene delivery. After ad hoc functionalization, we found that oxo-G is able to efficiently complex siRNA and strongly induce gene silencing in vitro at 5 pg/cell doses, more than 1 order of magnitude lower than the best results reported in the literature using graphene-based materials. The aim of this work is to inspire the readers to develop further oxo-G materials for biomedical applications. We hope that oxo-G may be considered as an alternative candidate in future gene silencing use in vivo.
The importance of molecular structure and functionalization of oxographene sheets for gene silencing
Cristian Gabellini;Paola Posocco;
2022-01-01
Abstract
Gene therapy has recently reached the front line in the treatments of different diseases. Although graphene oxide has been widely used as a gene vector, its clinical application is limited by its scarce inhomogeneity due to the different synthetic methods adopted for its synthesis. Recently, we have developed the preparation of a new classof graphene oxide, named oxo -G,obtained by a rigorous synthetic method with controlled size and surface chemistry. oxo-G has been successfully applied for the production of reduced graphene oxide with remarkable conductivity. Here, we applied oxo-G to gene delivery. After ad hoc functionalization, we found that oxo-G is able to efficiently complex siRNA and strongly induce gene silencing in vitro at 5 pg/cell doses, more than 1 order of magnitude lower than the best results reported in the literature using graphene-based materials. The aim of this work is to inspire the readers to develop further oxo-G materials for biomedical applications. We hope that oxo-G may be considered as an alternative candidate in future gene silencing use in vivo.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S0008622322002469-main.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
2.54 MB
Formato
Adobe PDF
|
2.54 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
3016768_1-s2.0-S0008622322002469-main-Post_print.pdf
Open Access dal 31/03/2024
Tipologia:
Bozza finale post-referaggio (post-print)
Licenza:
Creative commons
Dimensione
2.99 MB
Formato
Adobe PDF
|
2.99 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.